Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Cns Pharmaceuticals stock
Learn how to easily invest in Cns Pharmaceuticals stock.
Cns Pharmaceuticals Inc is a biotechnology business based in the US. Cns Pharmaceuticals shares (CNSP) are listed on the NASDAQ and all prices are listed in US Dollars. Cns Pharmaceuticals employs 3 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy shares in Cns Pharmaceuticals
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – CNSP – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Cns Pharmaceuticals stock price (NASDAQ: CNSP)Use our graph to track the performance of CNSP stocks over time.
Cns Pharmaceuticals shares at a glance
|Latest market close||$0.18|
|52-week range||$0.17 - $1.55|
|50-day moving average||$0.23|
|200-day moving average||$0.37|
|Wall St. target price||$10.00|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-0.44|
Buy Cns Pharmaceuticals shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Cns Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Cns Pharmaceuticals price performance over time
|1 week (2022-09-28)||-7.69%|
|1 month (2022-09-02)||-27.36%|
|3 months (2022-07-05)||-31.06%|
|6 months (2022-04-01)||-47.06%|
|1 year (2021-10-05)||-87.41%|
|2 years (2020-10-05)||-90.27%|
|3 years (2019-10-01)||N/A|
|5 years (2017-10-01)||N/A|
Cns Pharmaceuticals financials
|Gross profit TTM||$0|
|Return on assets TTM||-60.67%|
|Return on equity TTM||-108.31%|
|Market capitalisation||$7.2 million|
TTM: trailing 12 months
Cns Pharmaceuticals share dividends
We're not expecting Cns Pharmaceuticals to pay a dividend over the next 12 months.
Cns Pharmaceuticals share price volatility
Over the last 12 months, Cns Pharmaceuticals's shares have ranged in value from as little as $0.166 up to $1.55. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Cns Pharmaceuticals's is 1.33. This would suggest that Cns Pharmaceuticals's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Cns Pharmaceuticals overview
CNS Pharmaceuticals, Inc. , a clinical pharmaceutical company, engages in the development of anti-cancer drug candidates for the treatment of brain and central nervous system tumors. The company's lead drug candidate is Berubicin, an anthracycline that is in Phase I and II clinical trials that is used for the treatment of glioblastoma multiforme. It has license agreements with Houston Pharmaceuticals, Inc. and The University of Texas M. D. Anderson Cancer Center, as well as Animal Life Sciences, LLC; and a development agreement with WPD Pharmaceuticals Inc.
Frequently asked questionsWhat percentage of Cns Pharmaceuticals is owned by insiders or institutions?
Currently 21.664% of Cns Pharmaceuticals shares are held by insiders and 3.043% by institutions. How many people work for Cns Pharmaceuticals?
Latest data suggests 3 work at Cns Pharmaceuticals. When does the fiscal year end for Cns Pharmaceuticals?
Cns Pharmaceuticals's fiscal year ends in December. Where is Cns Pharmaceuticals based?
Cns Pharmaceuticals's address is: 2100 West Loop South, Houston, TX, United States, 77027 What is Cns Pharmaceuticals's ISIN number?
Cns Pharmaceuticals's international securities identification number is: US18978H1023 What is Cns Pharmaceuticals's CUSIP number?
Cns Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 155184104
More guides on Finder
How to buy YanGuFang International Group (YGF) stock when it goes public
Everything we know about the YanGuFang International Group IPO, plus information on how to buy in.
What are the FAANG stocks and how do you invest in them?
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
How to buy soccer stocks
A simple guide to buying stocks in your favorite European soccer team.
How to buy Juventus stock
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
How to buy AS Roma stock
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
How to buy Borussia Dortmund stock
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
How to buy Lead Real Estate Co. (LRE) stock when it goes public
Everything we know about the Lead Real Estate Co. IPO, plus information on how to buy in.
How to buy Third Harmonic Bio (THRD) stock
Everything we know about the Third Harmonic Bio IPO, plus information on how to buy in.
How to buy LINKBANCORP (LNKB) stock
Everything we know about the LINKBANCORP IPO, plus information on how to buy in.
Here are the stocks that benefit from inflation, as well as industries to keep an eye on to reduce the impacts of inflation on your portfolio.
Ask an Expert